Kenneth B. Lee Jr., Director at Aralez Pharmaceuticals Inc. (ARLZ), bought 1,000 shares at $3.50 ($4K) on 2016-05-13, disclosed to the SEC on 2016-05-17.
Open-market purchase of $4k ARLZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| EYEN | BUY | 2021-06-15 | $33K | — | Filing → |
| BCRX | BUY | 2019-11-18 | $7K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $13K | — | Filing → |